Skip to main content
FinSpry Logo
FinSpry
KNSA logo
KNSA
(NASDAQ)
Kiniksa Pharmaceuticals International, plc
$80.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kiniksa Pharmaceuticals International (KNSA) Stock Price & Financial Analysis

Kiniksa Pharmaceuticals International Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$79.13 - $80.86
52-Week High$82.94
52-Week Low$32.89
Open$79.36
Volume401.97K
Average Volume (3M)622.25K
Market Cap6.69B
Shares Outstanding83.40M
P/E Ratio (TTM)82.92
Forward P/E40.12
Price to Sales (P/S)7.95
Price to Book (P/B)10.22
EV/EBITDA59.97
Revenue (TTM)840.85M
Net Income (TTM)80.66M
Free Cash Flow (TTM)182.84M
EPS (TTM)$1.00
Profit Margin9.59%
Operating Margin11.92%
Return on Equity (ROE)12.33%
Debt to Equity0.01
50-Day MA$68.15
200-Day MA$51.32
52-Week Change142.74%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Kiniksa Pharmaceuticals International

What is the current stock price for KNSA?

As of the latest trading session, KNSA stock trades at $80.20. The 52-week range is $32.89–$82.94, with a day range of $79.13–$80.86.

What is the P/E ratio for KNSA?

Kiniksa Pharmaceuticals International's trailing P/E ratio is 82.9, meaning investors pay $82.9 for every $1 of annual earnings. The forward P/E is 40.1, reflecting analyst expectations for future earnings. Kiniksa Pharmaceuticals International operates in the Healthcare sector.

Does KNSA pay dividends?

Kiniksa Pharmaceuticals International does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KNSA?

Based on 4 analysts, the consensus for KNSA is Buy.

What is the market cap of KNSA?

Kiniksa Pharmaceuticals International's market capitalization is $6.69B, classifying it as a mid-cap company. Kiniksa Pharmaceuticals International operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.